A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA

NCT05601128 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

HIV-1-infection
HIV Infections
HIV I Infection

Interventions

DRUG: CAB + RPV

Sponsor

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)